GLENMARK LIFE SCIENCES
Back to Balance Sheet
|
GLENMARK LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr | ₹1,307 Cr |
What is the latest Total Current Liabilities ratio of GLENMARK LIFE SCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹439 Cr |
Mar2023 | ₹1,015 Cr |
Mar2022 | ₹747 Cr |
Mar2021 | ₹1,445 Cr |
Mar2020 | ₹1,307 Cr |
How is Total Current Liabilities of GLENMARK LIFE SCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹439 Cr | -56.77 | |
Mar2023 | ₹1,015 Cr | 35.90 | |
Mar2022 | ₹747 Cr | -48.32 | |
Mar2021 | ₹1,445 Cr | 10.51 | |
Mar2020 | ₹1,307 Cr | - |
Compare Total Current Liabilities of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,309.0 Cr | -0.6% | 7% | 70.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,478.0 Cr | -1.3% | -4.8% | 45% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,822.0 Cr | 0.5% | 6.4% | 58.2% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.1% | 3.8% | 24.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,322.0 Cr | -0.6% | -5.7% | 5.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,217.3 Cr | 0.1% | -3.6% | 48.2% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -0.6% |
7% |
70.9% |
SENSEX | 0.9% |
-0.3% |
20.9% |
You may also like the below Video Courses